EUROPEAN MEDICAL JOURNAL SUMMARIES
Prof. Pavlov EMJ webinar summary
Read the key points from Prof. Pavlov presentation at the EMJ webinar
RWE in current NAFLD landscape
Find out what your peers use in their daily clinical practice to diagnose and treat NAFLD
Essential Phospholipids (EPL) in NAFLD
Learn how your peers use EPLs in the NAFLD continuum
NAFLD and metabolic comorbidities
Discover what other HCPs think are the risk factors associated to NAFLD
NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) & DIAGNOSIS
NAFLD burden and Ultrasound importance
Find out how NAFLD has an impact on healthcare resources and why it should be treated
Guidelines
Discover why the recent guidelines recommend ultrasound for NAFLD diagnosis
PATIENT CASES
Maria - Metabolic Syndrome patient
Learn about the most common profiles of patients with NAFLD
Sergei - Ischemic heart disease patient
Learn about the most common profiles of patients with NAFLD
Valentina - Type 2 diabetes patient
Learn about the most common profiles of patients with NAFLD
ESSENTIAL PHOSPHOLIPIDS (EPL) EVIDENCE
Prof Pavlov NAFLD & Comorbidities video
Find out more about results Manpower study from Professor Pavlov
Prof Pavlov Liver Structure improvement shown by ultrasound video
Find out more about how EPL treatment improved liver structure in Manpower study
Prof Pavlov Improvement of lipid profile
Find out more about how EPL treatment improved lipid profile in NAFLD patients shown in Manpower study
Prof Pavlov Improvement of enzyme levels
Find out more about how EPL treatment improved enzyme levels in NAFLD patients shown in Manpower study
Essentiale Manpower 3 Explainer Video
Watch this video to learn results of Manpower real world data study
Essentiale Manpower 2 Explainer Video
Watch this video to learn results of Manpower real world data study
EPLs vs competitors
Explore how efficacy and safety of Essential Phospholipids compare to other Treatment Options
MOA
Learn how Essential Phospholipids work and why they reduce steatosis
Prof Dajani open label study
Read the summary of a randomized open label study of EPL added to the treatment of primary NAFLD
Open label study of EPL outcomes
Watch Prof. Dajani explaining the outcomes of a randomized open label study of EPL added to the treatment of primary NAFLD
MANPOWER study 1
Find out how many patients with Diabetes, Metabolic syndrome and hypertension have NAFLD in this Real-World Evidence study in Russia
MANPOWER study 1
Download the slides to learn the prevalence of NAFLD in patients with diabetes, hypertension and metabolic syndrome.
MANPOWER study 1
Watch this video to learn how many patients with Diabetes, Metabolic syndrome and hypertension have NAFLD in this Real-World Evidence study in Russia
